Preview: Intellia Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Intellia Therapeutics (NASDAQ:NTLA) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $-1.32. The company's stock performance has been generally negative over the last 52-week period, with shares down 39.78%. Last quarter, the company beat EPS by $0.23, resulting in a 0.57% increase in share price the next day.
August 04, 2023 | 11:24 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Intellia Therapeutics is expected to report an EPS of $-1.32. The company's shares have been on a downward trend, decreasing by 39.78% over the past year.
The company's stock has been on a downward trend, which may continue if the earnings report is not positive. Last quarter's earnings beat led to a slight increase in share price, indicating that the market reacts to the company's financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100